APG-2575
Showing 1 - 25 of 42
Breast Cancer, Solid Tumor, Adult Trial in United States (APG-2575, Palbociclib)
Recruiting
- Breast Cancer
- Solid Tumor, Adult
- APG-2575
- Palbociclib
-
Atlanta, Georgia
- +3 more
Aug 12, 2022
Hematologic Malignancies Trial in Australia, United States (APG-2575)
Recruiting
- Hematologic Malignancies
- APG-2575
-
Jacksonville, Florida
- +4 more
Aug 12, 2022
AML, Adult Trial in Australia, China, United States (APG 2575 ramp up arm)
Recruiting
- AML, Adult
- APG 2575 ramp up arm
-
Baltimore, Maryland
- +6 more
Aug 12, 2022
Multiple Myeloma, Amyloidosis Trial in Jacksonville, New York, Cleveland (APG-2575+ Pd, APG-2575 + DRd)
Recruiting
- Multiple Myeloma
- Amyloidosis
- APG-2575+ Pd
- APG-2575 + DRd
-
Jacksonville, Florida
- +2 more
Feb 28, 2022
Lymphoblastic Leukemia, Acute, Childhood, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Relapsed Leukemia Trial in
Not yet recruiting
- Lymphoblastic Leukemia, Acute, Childhood
- +3 more
- Olverembatinib, APG-2575, Dexamethasone
-
Hefei, Anhui, China
- +3 more
Aug 8, 2022
Chronic Lymphocytic Leukemia, Non Hodgkin Lymphoma Trial in China (APG-2575)
Recruiting
- Chronic Lymphocytic Leukemia
- Non Hodgkin Lymphoma
- APG-2575
-
Hefei, Anhui, China
- +4 more
Feb 23, 2022
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)
Recruiting
- Relapsed/Refractory Acute Myeloid Leukaemia
- Myeloid Malignancy
- APG-2575
- +3 more
-
Beijing, Beijing, China
- +9 more
Jan 10, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (APG-2575, Rituximab, Ibrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- APG-2575
- +2 more
-
Beijing, Beijing, China
- +17 more
Sep 2, 2021
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (APG2575)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
-
Bengbu, Anhui, China
- +45 more
Jun 30, 2022
Nasopharyngeal Carcinoma, Castrate Resistant Prostate Cancer, Gastric Cancer Trial in New Haven (APG-5918)
Recruiting
- Nasopharyngeal Carcinoma
- +8 more
-
Springdale, ArkansasHighlands Oncology
Nov 11, 2022
Oropharyngeal Dysplasia, Oral Cavity Dysplasia, Oral Carcinoma in Situ Trial in Miami (APG-157)
Not yet recruiting
- Oropharyngeal Dysplasia
- +2 more
-
Miami, FloridaUniversity of Miami
May 9, 2023
Anemia Trial in Guangzhou (APG-5918, Placebo)
Not yet recruiting
- Anemia
- APG-5918
- Placebo
-
Guangzhou, Guangdong, ChinaNanfang Hospital of Southern Medical University
Mar 6, 2023
Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma Trial (Biopsy, Biospecimen
Not yet recruiting
- Metastatic Endometrial Carcinoma
- +7 more
- Biopsy
- +5 more
- (no location specified)
Jan 18, 2023
Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)
Recruiting
- Malignant Salivary Gland Cancer
- Salivary Gland Cancer
-
Tampa, Florida
- +2 more
Feb 10, 2022
Acute Myeloid Leukemia (AML), MDS (MDS) Trial in China (APG-115, Azacitidine, Cytarabine)
Recruiting
- Acute Myeloid Leukemia (AML)
- Myelodysplastic Syndromes (MDS)
- APG-115
- +2 more
-
Beijing, Beijing, China
- +13 more
Aug 16, 2022